South Korea · Delayed Price · Currency is KRW EASY BIO,Inc. Statistics
Total Valuation
EASY BIO,Inc. has a market cap or net worth of KRW 241.83 billion. The enterprise value is 338.60 billion.
| Market Cap | 241.83B |
| Enterprise Value | 338.60B |
Important Dates
The next estimated earnings date is Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | Mar 9, 2026 |
Share Statistics
EASY BIO,Inc. has 33.08 million shares outstanding. The number of shares has decreased by -2.33% in one year.
| Current Share Class | 33.08M |
| Shares Outstanding | 33.08M |
| Shares Change (YoY) | -2.33% |
| Shares Change (QoQ) | -0.16% |
| Owned by Insiders (%) | 1.37% |
| Owned by Institutions (%) | 0.43% |
| Float | 16.04M |
Valuation Ratios
The trailing PE ratio is 8.70 and the forward PE ratio is 5.84.
| PE Ratio | 8.70 |
| Forward PE | 5.84 |
| PS Ratio | 0.51 |
| PB Ratio | 2.13 |
| P/TBV Ratio | 5.42 |
| P/FCF Ratio | 8.40 |
| P/OCF Ratio | 6.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.35, with an EV/FCF ratio of 11.76.
| EV / Earnings | 12.19 |
| EV / Sales | 0.71 |
| EV / EBITDA | 6.35 |
| EV / EBIT | 7.53 |
| EV / FCF | 11.76 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 1.35.
| Current Ratio | 1.35 |
| Quick Ratio | 0.75 |
| Debt / Equity | 1.35 |
| Debt / EBITDA | 2.87 |
| Debt / FCF | 5.31 |
| Interest Coverage | 5.97 |
Financial Efficiency
Return on equity (ROE) is 28.93% and return on invested capital (ROIC) is 15.65%.
| Return on Equity (ROE) | 28.93% |
| Return on Assets (ROA) | 8.18% |
| Return on Invested Capital (ROIC) | 15.65% |
| Return on Capital Employed (ROCE) | 23.98% |
| Weighted Average Cost of Capital (WACC) | 6.62% |
| Revenue Per Employee | 3.61B |
| Profits Per Employee | 210.44M |
| Employee Count | 132 |
| Asset Turnover | 1.39 |
| Inventory Turnover | 6.46 |
Taxes
In the past 12 months, EASY BIO,Inc. has paid 9.39 billion in taxes.
| Income Tax | 9.39B |
| Effective Tax Rate | 24.28% |
Stock Price Statistics
The stock price has increased by +44.47% in the last 52 weeks. The beta is 0.76, so EASY BIO,Inc.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | +44.47% |
| 50-Day Moving Average | 7,237.20 |
| 200-Day Moving Average | 6,176.20 |
| Relative Strength Index (RSI) | 53.25 |
| Average Volume (20 Days) | 156,898 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EASY BIO,Inc. had revenue of KRW 476.94 billion and earned 27.78 billion in profits. Earnings per share was 840.00.
| Revenue | 476.94B |
| Gross Profit | 120.49B |
| Operating Income | 44.99B |
| Pretax Income | 38.66B |
| Net Income | 27.78B |
| EBITDA | 53.32B |
| EBIT | 44.99B |
| Earnings Per Share (EPS) | 840.00 |
Balance Sheet
The company has 62.46 billion in cash and 152.87 billion in debt, with a net cash position of -90.41 billion or -2,732.79 per share.
| Cash & Cash Equivalents | 62.46B |
| Total Debt | 152.87B |
| Net Cash | -90.41B |
| Net Cash Per Share | -2,732.79 |
| Equity (Book Value) | 113.56B |
| Book Value Per Share | 3,240.14 |
| Working Capital | 48.81B |
Cash Flow
In the last 12 months, operating cash flow was 34.65 billion and capital expenditures -5.87 billion, giving a free cash flow of 28.78 billion.
| Operating Cash Flow | 34.65B |
| Capital Expenditures | -5.87B |
| Depreciation & Amortization | 8.33B |
| Net Borrowing | -56.96B |
| Free Cash Flow | 28.78B |
| FCF Per Share | 870.02 |
Margins
Gross margin is 25.26%, with operating and profit margins of 9.43% and 5.82%.
| Gross Margin | 25.26% |
| Operating Margin | 9.43% |
| Pretax Margin | 8.11% |
| Profit Margin | 5.82% |
| EBITDA Margin | 11.18% |
| EBIT Margin | 9.43% |
| FCF Margin | 6.03% |
Dividends & Yields
This stock pays an annual dividend of 250.00, which amounts to a dividend yield of 3.37%.
| Dividend Per Share | 250.00 |
| Dividend Yield | 3.37% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 24.07% |
| Buyback Yield | 2.33% |
| Shareholder Yield | 5.71% |
| Earnings Yield | 11.49% |
| FCF Yield | 11.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 21, 2020. It was a forward split with a ratio of 5.
| Last Split Date | Dec 21, 2020 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
EASY BIO,Inc. has an Altman Z-Score of 2.93 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.93 |
| Piotroski F-Score | 5 |